Literature DB >> 15798220

Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity.

Bipin C Dash1, Wafik S El-Deiry.   

Abstract

Little is known about the posttranslational control of the cyclin-dependent protein kinase (CDK) inhibitor p21. We describe here a transient phosphorylation of p21 in the G2/M phase. G2/M-phosphorylated p21 is short-lived relative to hypophosphorylated p21. p21 becomes nuclear during S phase, prior to its phosphorylation by CDK2. S126-phosphorylated cyclin B1 binds to T57-phosphorylated p21. Cdc2 kinase activation is delayed in p21-deficient cells due to delayed association between Cdc2 and cyclin B1. Cyclin B1-Cdc2 kinase activity and G2/M progression in p21-/- cells are restored after reexpression of wild-type but not T57A mutant p21. The cyclin B1 S126A mutant exhibits reduced Cdc2 binding and has low kinase activity. Phosphorylated p21 binds to cyclin B1 when Cdc2 is phosphorylated on Y15 and associates poorly with the complex. Dephosphorylation on Y15 and phosphorylation on T161 promotes Cdc2 binding to the p21-cyclin B1 complex, which becomes activated as a kinase. Thus, hyperphosphorylated p21 activates the Cdc2 kinase in the G2/M transition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798220      PMCID: PMC1069593          DOI: 10.1128/MCB.25.8.3364-3387.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  82 in total

1.  Ionizing radiation activates the ATM kinase throughout the cell cycle.

Authors:  T K Pandita; H B Lieberman; D S Lim; S Dhar; W Zheng; Y Taya; M B Kastan
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

2.  ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

Authors:  C A Hall-Jackson; D A Cross; N Morrice; C Smythe
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

Review 4.  Mammalian G1 cyclins.

Authors:  C J Sherr
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

5.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

6.  G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.

Authors:  P M O'Connor; D K Ferris; M Pagano; G Draetta; J Pines; T Hunter; D L Longo; K W Kohn
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

7.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

8.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.

Authors:  S Waga; G J Hannon; D Beach; B Stillman
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

9.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes.

Authors:  H Zhang; Y Xiong; D Beach
Journal:  Mol Biol Cell       Date:  1993-09       Impact factor: 4.138

View more
  49 in total

1.  Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB.

Authors:  Sunil K Manna; Julie S Bose; Vijay Gangan; Nune Raviprakash; Thota Navaneetha; Pongali B Raghavendra; Banaganapalli Babajan; Chitta S Kumar; Swatantra K Jain
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

2.  VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells.

Authors:  Lymor Ringer; Paul Sirajuddin; Mary Heckler; Anup Ghosh; Frank Suprynowicz; Venkata M Yenugonda; Milton L Brown; Jeffrey A Toretsky; Aykut Uren; YiChien Lee; Tobey J MacDonald; Olga Rodriguez; Robert I Glazer; Richard Schlegel; Chris Albanese
Journal:  Cancer Biol Ther       Date:  2011-11-01       Impact factor: 4.742

3.  Identification of candidate genes for paratuberculosis resistance in the native Italian Garfagnina goat breed.

Authors:  Francesca Cecchi; Claudia Russo; Daniela Iamartino; Alessia Galiero; Barbara Turchi; Filippo Fratini; Sara Degl'Innocenti; Raffaele Mazza; Stefano Biffani; Giovanna Preziuso; Carlo Cantile
Journal:  Trop Anim Health Prod       Date:  2017-05-19       Impact factor: 1.559

4.  Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells.

Authors:  Liu-Jun He; Dong-Lin Yang; Shi-Qiang Li; Ya-Jun Zhang; Yan Tang; Jie Lei; Brendan Frett; Hui-Kuan Lin; Hong-Yu Li; Zhong-Zhu Chen; Zhi-Gang Xu
Journal:  Bioorg Med Chem       Date:  2018-06-12       Impact factor: 3.641

5.  p21 overexpression sensitizes osteosarcoma U2OS cells to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade.

Authors:  Yong Ding; Yucai Wang; Jun Chen; Yunsheng Hu; Zhuo Cao; Pengcheng Ren; Yong Zhang
Journal:  Tumour Biol       Date:  2013-12-11

6.  Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin.

Authors:  Mo Zhou; Jinkai Zheng; Jinfeng Bi; Xinye Wu; Jian Lyu; Kun Gao
Journal:  Oncol Lett       Date:  2017-11-23       Impact factor: 2.967

7.  Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment.

Authors:  Débora Rosa Bublik; Massimiliano Scolz; Gianluca Triolo; Martín Monte; Claudio Schneider
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

8.  Serine 123 phosphorylation modulates p21 protein stability and activity by suppressing ubiquitin-independent proteasomal degradation.

Authors:  Xiangling Chen; Jin Zhang; Min Zhang; Shou Liu; Wensheng Yan; JinHyuk Jung; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

Review 9.  Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.

Authors:  Yingmei Wang; Ping Ji; Jinsong Liu; Russell R Broaddus; Fengxia Xue; Wei Zhang
Journal:  Mol Cancer       Date:  2009-02-13       Impact factor: 27.401

10.  p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker.

Authors:  Magdalena B Flak; Claire M Connell; Claude Chelala; Kyra Archibald; Michael A Salako; Katrina J Pirlo; Michelle Lockley; Sally P Wheatley; Frances R Balkwill; Iain A McNeish
Journal:  Mol Cancer       Date:  2010-07-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.